# Gaia AG clinical trials: 21 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials with Gaia AG as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Gaia AG: 21 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/gaia-ag

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07947095 | Investigating the Effectiveness of Calisda, a Digital Health Intervention for Patients With Menopause Symptoms | Gaia AG | Not applicable | Not yet recruiting | Menopause Symptoms | 388 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947095) |
| June 10, 2026 | NCT07638657 | Investigating Autimia, a Digital Intervention for Patients With Autism Spectrum Disorder | Gaia AG | Not applicable | Recruiting | Autism Spectrum Disorder | 236 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07638657) |
| September 19, 2024 | NCT06601907 | Researching the Effectiveness of a Alivis, a Digital Health Application for Borderline Personality Disorder | Gaia AG | Not applicable | Terminated | Borderline Personality Disorder (BPD) | 286 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06601907) |
| July 31, 2024 | NCT06529965 | Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM | Gaia AG | Not applicable | Active not recruiting | Glucose Metabolism Disorders (Including Diabetes Mellitus), Metabolic Disease, Endocrine System Diseases, Diabetes... | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06529965) |
| February 9, 2024 | NCT06251518 | Investigating the Effectiveness of Vimida | Gaia AG | Not applicable | Completed | Long COVID, Post COVID-19 Condition | 176 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06251518) |
| February 6, 2024 | NCT06243978 | Effectiveness of a Digital Health Application for Primary Hypertension (Liebria) | Gaia AG | Not applicable | Active not recruiting | Hypertension | 328 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06243978) |
| February 1, 2024 | NCT06237166 | Evaluation of an Online Intervention for Female Sexual Dysfunction | Gaia AG | Not applicable | Completed | Female Sexual Dysfunction | 252 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06237166) |
| January 24, 2024 | NCT06221956 | Effectiveness of a Digital Health Application for Subacute and Chronic Back Pain (Relevis) | Gaia AG | Not applicable | Unknown | Back Pain | 276 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06221956) |
| January 24, 2024 | NCT06221930 | Researching the Effectiveness of Attexis, a Digital Health Application for Adults With Attention Deficit Hyperactivity Disorder | Gaia AG | Not applicable | Completed | Adult Attention Deficit Hyperactivity Disorder | 337 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06221930) |
| October 19, 2023 | NCT06090305 | Effectiveness of a Digital Health Application for Multiple Sclerosis (Levidex) | Gaia AG | Not applicable | Completed | Multiple Sclerosis | 470 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06090305) |
| September 7, 2023 | NCT06027034 | Effectiveness of a Digital Health Application for Psoriasis | Gaia AG | Not applicable | Completed | Psoriasis | 348 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06027034) |
| August 18, 2023 | NCT05998161 | Evaluating the Effectiveness of a Digital Therapeutic (Reviga) for People With Stress or Burnout | Gaia AG | Not applicable | Completed | Stress, Burnout | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05998161) |
| August 14, 2023 | NCT05988866 | Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels | Gaia AG | Not applicable | Completed | Hypercholesterolemia, Dyslipidemias | 278 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05988866) |
| April 21, 2023 | NCT05824611 | Formative Validation of the MoveChecker System | Gaia AG | Observational | Completed | Epilepsy | 53 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05824611) |
| September 28, 2022 | NCT05558865 | Effectiveness of a Digital Health Application for People With Insomnia Disorder (Somnovia) | Gaia AG | Not applicable | Completed | Insomnia Disorder | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05558865) |
| September 7, 2022 | NCT05529797 | Effect of a Single Virtual Reality Exposure on Depressive Symptoms (Veovita-VR) | Gaia AG | Not applicable | Completed | Depression | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05529797) |
| September 1, 2022 | NCT05525117 | Effectiveness of an Online Self-management Intervention for Type 2 Diabetes Mellitus | Gaia AG | Not applicable | Withdrawn | Type 2 Diabetes | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05525117) |
| June 11, 2020 | NCT04428450 | Internet-Based Treatment of Depression: Comparing Guided With Unguided Self-Help | Gaia AG | Not applicable | Completed | Depression | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04428450) |
| February 19, 2020 | NCT04276142 | Effectiveness of a Dialogue-based Online Intervention Against Migraine | Gaia AG | Not applicable | Completed | Migraine | 321 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04276142) |
| February 1, 2018 | NCT03418142 | Evaluating an Internet-Based Self-Management Intervention for Borderline | Gaia AG | Not applicable | Completed | Borderline Personality Disorder | 206 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03418142) |
| June 7, 2016 | NCT02791724 | Evaluating a Novel Internet Intervention for Persons With Epilepsy and Depression | Gaia AG | Not applicable | Completed | Depression, Epilepsy | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02791724) |

## By phase

| Phase | Trials |
| --- | --- |
| Not applicable | 20 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 14 |
| Active not recruiting | 2 |
| Unknown | 1 |
| Withdrawn | 1 |
| Terminated | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Depression | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Epilepsy | 2 |
| Borderline Personality Disorder | 2 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Hypertension | 1 |
| Sleep Initiation and Maintenance Disorders | 1 |
| Burnout, Psychological | 1 |
| Glucose Metabolism Disorders | 1 |
| Metabolic Diseases | 1 |
| Endocrine System Diseases | 1 |
| Back Pain | 1 |
| Psoriasis | 1 |
| Post-Acute COVID-19 Syndrome | 1 |
| Migraine Disorders | 1 |
| Headache | 1 |
| Hypercholesterolemia | 1 |
| Dyslipidemias | 1 |
| Multiple Sclerosis | 1 |
| Autism Spectrum Disorder | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Tapas bars in the United States](https://specstream.ai/data/businesses/tapas-bars/united-states)
- [Logging contractors in the United States](https://specstream.ai/data/businesses/logging-contractors/united-states)
- [Cuban restaurants in the United States](https://specstream.ai/data/businesses/cuban-restaurants/united-states)
- [Vehicle parts manufacturers in the United States](https://specstream.ai/data/businesses/vehicle-parts-manufacturers/united-states)
- [Neurology practices in the United States](https://specstream.ai/data/businesses/neurology-practices/united-states)
- [Emergency and urgent care facilities in the United States](https://specstream.ai/data/businesses/emergency-and-urgent-care-facilities/united-states)
